May 17, 2017
LUNCH & LEARN—CLINICAL AND RESEARCH LC/MS/MS
Getting the Most Out of Your LC/MS/MS
Clinical and pharmaceutical applications
In our last ALT lunch & learn, we covered gas chromatography basics and maintenance tips. This time, we make the move to LC/MS/MS. In this edition of our educational series, Dr. Daniel Kassel, founder & CEO of SciAnalytical Strategies, Inc., will share information to help you get the most out of your LC/MS/MS.
The program will cover high-sensitivity, high-performance applications in both clinical and pharmaceutical settings.
Date: Wednesday, June 7, 2017
Location: American Laboratory Trading, San Diego
6444 Nancy Ridge Dr., San Diego, CA 92121
Time: 12:00 p.m. to 1:00 p.m.
About the presenter
Daniel Kassel, PhD, Founder & CEO, SciAnalytical Strategies, Inc., 505 Coast Blvd. South, La Jolla, CA 92037
Dr. Kassel founded SciAnalytical Strategies in 2013, a bioanalytical, biomarker discovery, and analytical testing laboratory that serves the pharmaceutical, biotechnology, and clinical industries. The company is located on the beautiful coast of La Jolla, CA.
Previously, Dr. Kassel served as Vice President of Analytical Sciences and DMPK at Takeda Pharmaceuticals (2005-2012). There, he led teams in the areas of high-throughput analysis, mass-directed purification, DMPK, and biomarker discovery and development. He also led several discovery research projects for Takeda, most notably an insulin-sparing oral therapy for Type 1 diabetes. Dr. Kassel was awarded the Takeda Global Award in 2008 for his work on Alogliptin, marketed in Japan and the U.S. for the treatment of Type 2 diabetes. He was also an invited participant in the Takeda Leadership Institute—the most prestigious leadership program within Takeda.
Dr. Kassel received his PhD from Michigan State University and was awarded an NIH NRSA fellowship at Harvard University. He has authored over 70 peer-reviewed manuscripts and more than 100 abstracts, and taught numerous short courses and workshops on mass spectrometry and drug discovery.